Author

Yajing Liu

Boehringer Ingelheim (Germany)Primary ORCID profile (0000-0001-9347-7665 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Yajing LiuiD1 paper · Henan Agricultural University

Biology Disciplines

Click to filter author papers

Microbiology· 1 Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:bacteria (other)· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Organism:mouse· 1 Research Focus:protein folding & dynamics· 1 Assay:proteomics· 1

Frequent Co-Authors

Abulimiti AikedaniD· 1 shared Broder RühmanniD· 1 shared Guillermo Coronas‐SamanoiD· 1 shared Hagen TilgneriD· 1 shared Jingjie ZhuiD· 1 shared Kendra Norman· 1 shared Laura Kampl· 1 shared Li FaniD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Abulimiti AikedanORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Unraveling Xanthomonas acetyltransferase GumG: decoding catalytic promiscuity, understanding the mechanism, and enhancing enzymatic versatility

Yajing Liu, Broder Rühmann, Okke Melse, Tenuun Bayaraa, Laura Kampl, Manuel Döring, Volker Sieber

This study characterizes GumG, an acetyltransferase involved in xanthan modification, revealing its substrate promiscuity and catalytic mechanism to enable engineered xanthan derivatives.

bioRxiv · Jun 23, 2026 · PreprintMicrobiology

cGAS inhibition delays TDP-43-driven ALS Pathogenesis

Yajing Liu, Weixi Feng, Abulimiti Aikedan, Se-In Lee, Maitreyee Bhagwat, Ravi Kumar Nagiri, Man Ying Wong, Sadaf Amin, Wenhui Qu, Jingjie Zhu, Si-Yu Wang, Pearly Ye, Kendra Norman, Guillermo Coronas‐Samano, Marta Olah, , Li Gan

This study identifies cGAS as a key mediator of TDP-43 pathology in ALS and shows that its inhibition reduces RNA splicing defects and neurodegeneration.

bioRxiv · Feb 26, 2026 · PreprintNeuroscience